ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.

导出原文传递

翻译打印收藏纠错

第一作者： Massimiliano,Salati

第一单位： Division of Oncology, Oncology and Hematology Department, University of Modena and Reggio Emilia, Modena, Italy.;Ph.D. Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.

作者： Massimiliano,Salati ^[1] ; Konstantinos,Venetis ^[2] ; Matteo,Fassan ^[3] ; Umberto,Malapelle ^[4] ; Fabio,Pagni ^[5] ; Elham,Sajjadi ^[2] ; Nicola,Fusco ^[2] ; Michele,Ghidini ^[6]

作者单位： Division of Oncology, Oncology and Hematology Department, University of Modena and Reggio Emilia, Modena, Italy.;Ph.D. Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy. ^[1] Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.;Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy. ^[2] Department of Medicine (DIMED), Surgical Pathology and Cytopathology Unit, University of Padua, Italy. ^[3] Department of Public Health, University of Naples Federico II, Naples, Italy. ^[4] Department of Medicine and Surgery, Pathology, University Milan Bicocca, Milan 20126, Italy. ^[5] Division of Medical Oncology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy. ^[6]

关键词 biomarker circulating tumor DNA ctDNA efficacy prediction gastric cancer gastroesophageal adenocarcinoma liquid biopsy minimal residual disease precision medicine prognosis